A-1211212

N/A

Report date: 2025/04/25 09:36:58

NME

Base Information

Drug NameA-1211212

Drug Alias NameA-1211212

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsApoptosis stimulants

TargetsApoptosis regulator Bcl-2

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Active CompaniesAbbvie Inc

Inactive CompaniesN/A

Active IndicationsInflammatory Bowel Diseases

Inactive IndicationsN/A

ATC CodeN/A